Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$161.19 - $257.96 $220,507 - $352,889
-1,368 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $4,951 - $6,089
-20 Reduced 1.44%
1,368 $362,000
Q3 2021

Oct 13, 2021

SELL
$194.77 - $324.21 $3,895 - $6,484
-20 Reduced 1.42%
1,388 $401,000
Q4 2020

Feb 08, 2021

BUY
$148.08 - $206.57 $208,496 - $290,850
1,408 New
1,408 $270,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.45B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Alta Wealth Advisors LLC Portfolio

Follow Alta Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alta Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alta Wealth Advisors LLC with notifications on news.